Protagonist Therapeutics
PTGX
PTGX
129 hedge funds and large institutions have $422M invested in Protagonist Therapeutics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 35
64% less capital invested
Capital invested by funds: $1.19B → $422M (-$765M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
129
Holding in Top 10
1
Calls
$18.8M
Puts
$4.96M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$20.3M | |
| 3 | +$17.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.03M |
| 5 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$5.82M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$24.3M | |
| 3 | -$18.9M | |
| 4 |
TLP
Tri Locum Partners
New York
|
-$18.2M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$13M |